MedPage Today on MSN1d
Broadly Neutralizing Antibodies Delayed Rebound in HIV Patients Who Stopped ART
Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral therapy (ART) ...
The American Journal of Managed Care8d
ART Approaches Differ Depending on the Patient
A survey of HIV health care providers in the US revealed the various approaches that providers took for prescribing ...
Gilead Presents New HIV Treatment And Cure Research Data
Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025). ALLIANCE is an ongoing ...
Healio1d
Two more people potentially cured of HIV
Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...
“Magic” for Those Who Can’t Take Pills: Groundbreaking HIV Treatment Achieves 98% Viral Suppression
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
Healio22h
‘We have come a long way’: Empirical data support UNAIDS HIV incidence estimates
HIV incidence in sub-Saharan Africa has declined substantially, according to both UNAIDS estimates and empirical data pulled ...
Monitor on MSN10hOpinion
Aid freeze hampering efforts to achieve zero discrimination for HIV patients
Funding cuts have disrupted HIV prevention, treatment, and care programmes, putting PLHIV at higher risk of infections and ...
Clinical Advisor5d
Updated Guidelines on Breastfeeding in HIV-Positive Mothers
HIV-positive mothers with undetectable viral load can now safely breastfeed their infants, according to recently updated ...